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Extracellular vesicles (EVs) are small lipid vesicles released by prokaryotic and eukaryotic
cells containing nucleic acids, proteins, and small metabolites essential for cellular
communication. Depending on the targeted cell, EVs can act either locally or in distant
tissues in a paracrine or endocrine cell signaling manner. Released EVs from virus-
infected cells, bacteria, fungi, or parasites have been demonstrated to perform a
pivotal role in a myriad of biochemical changes occurring in the host and pathogen,
including the modulation the immune system. In the past few years, the biology of
Trypanosoma cruzi EVs, as well as their role in innate immunity evasion, has been
started to be unveiled. This review article will present findings on and provide a
coherent understanding of the currently known mechanisms of action of T. cruzi-EVs
and hypothesize the implication of these parasite components during the acute and
chronic phases of Chagas disease.
Keywords: Leishmania spp., Trypanosoma brucei, Trypanosoma cruzi, kinetoplastids, exosome, ectosome,
microvesicle, pathogen
INTRODUCTION
EVs and T. cruzi Life Cycle
The term extracellular vesicles (EVs) is typically used to designate a compendium of different
membrane-bound entities delimited by a lipid bilayer and released to the extracellular space
by any type of prokaryotic or eukaryotic cell (Kalra et al., 2016). Although the populations of
these nanosized vesicles are very heterogeneous, they are usually classified according to their
biogenesis and size into three different categories: exosomes (40–150 nm), microvesicles (MVs)
(= ectosomes/microparticles) (100–1,000 nm) and apoptotic bodies (500–4,000 nm) (Akers et al.,
2013). The exosomes are of endocytic origin and are released into the medium through the fusion of
multivesicular body (MVB) formed from the endo/lysosomal system with the plasma membrane of
the cell, MVs are released by budding of the plasma membrane and finally apoptotic bodies which
are formed through the condensation and segregation of the nucleus and the deterioration and
blebbing of the plasma membrane (Akers et al., 2013). Despite their small size, the composition of
the different EVs is rather complex including a wide variety of lipids, proteins, different populations
of RNAs, ssDNA, and/or metabolites. Typically, the internal volume of an exosome ranges from 20
to 90 nm3, which suggests that a prototypical exosome roughly contains 100 proteins and 10,000
nucleotides (Vlassov et al., 2012), a figure that should be substantially higher in larger entities such
as ectosomes or apoptotic bodies.
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During the past decade, numerous studies have been
conducted on EVs in the context of disease. Since EVs
are virtually released by any cell type, hosts, and pathogens
will be constantly shedding and sharing these products to
the extra- or intracellular milieu (depending on the niche
for proliferation used by the pathogen). In this context,
EVs from flagellated protozoan parasites belonging to the
order Kinetoplastida are being described and characterized.
Kinetoplastids have monoxenous or dixenous life cycles, in which
different kinetoplastid forms thrive surrounded by different cell
types in the vector and the host. This large number of niches and
environments creates a myriad of different EVs released, which
will define parasite biodistribution, survival, and pathogenesis.
Within this group of organisms, Trypanosoma cruzi can be
found, which is the etiological agent of Chagas disease, a
devastating endemic disease in 21 South and Central American
countries, affecting around 6–7 million people worldwide, with
50,000 to 200,000 new cases each year (Coura et al., 2014).
T. cruzi is an obligatory dixenous parasite, transmitted by
hematophagous reduviid insects, which comprises zoonotic
and anthroponotic life cycles. The life cycle of this parasite
begins when hematophagous triatomine insect vectors ingest
circulating bloodstream trypomastigote forms whilst having a
blood meal from infected mammals such as humans (Figure 1A).
The ingested bloodstream trypomastigotes will migrate to the
FIGURE 1 | The life cycle of Trypanosoma cruzi. (A) Bloodstream
trypomastigotes (green) are ingested with the bloodmeal by the reduviid
vector. (B) Those forms will transform into epimastigotes (purple) and
intermediate spheromastigotes forms (red) in the insect midgut. (C) New
developmental differentiation into metacyclic trypomastigotes (MTs) (orange)
will occur in the insect rectum before those forms are released with the feces,
infecting the mammalian host. (D) The MTs (1st round of intracellular
replication) or bloodstream trypomastigotes (green) parasites will then invade
a wide range of nucleated cells in an intracellular cycle composed of up to
four steps: (1) Attachment, invasion, and parasitophorous vacuole formation
(0–4 h). (2) Differentiation into intracellular amastigote forms and release from
parasitophorous vacuole (12–24 h). (3) Amastigote replication by binary fission
(24–72 h). (4) Differentiation into bloodstream trypomastigotes and release
from the infected host cell (72–120 h). The bloodstream forms are then ready
to either invade new cells or been taken by the insect vector. Parasite life cycle
stage abbreviations: AMA, amastigotes; META, metacyclic trypomastigotes;
TRYPO, bloodstream trypomastigote; EPI, epimastigotes; SPHERO,
spheromastigotes.
insect vector midgut and differentiate into epimastigote forms,
the main replicative stage, as well as into spheromastigotes,
although in lower numbers (Figure 1B). Following attachment of
epimastigotes to the wax layer of rectal cuticula, these forms will
differentiate into the infective metacyclic trypomastigote (MT)
forms in the insect rectum, after adhesion of the epimastigotes
to the intestinal wall (Figure 1C). Then, the infective MTs
will be released with the feces of the triatomine insect and
invade epithelial and peripheral cells surrounding next to
the wound (Figure 1D). The MT forms will transform into
intracellular amastigote forms within approximately 24 h in
the cytoplasm of the infected cell, giving rise to successive
rounds of divisions by binary fission within 24–72 h after the
infection of the host cell (Li et al., 2016) (Figure 1D). Once
these forms occupy the entire cytoplasm of the host cell, they
will differentiate into bloodstream forms (96–120 h), which
will then be released from the infected cell to the bloodstream
resulting in the infection of a large number of tissues. This
high tissue distribution is concomitant with the onset of the
“acute phase” of the disease (fatal for 2–8% of the infected
subjects) lasting for approximately 2 months. This phase is
usually asymptomatic including mild symptomatology (fever,
headache, or muscle pain) and with large numbers of detectable
circulating bloodstream trypomastigotes. This high parasitemia
activates an immune response (Rassi et al., 2010), which results
in the reduction of parasite numbers to very low levels (in
immunocompetent hosts) and the onset of the “chronic phase”
Subjects who enter this stage can either be asymptomatic
which may result in a subclinical disease that lasts for decades
or symptomatic with 10–40% of infected patients developing
cardiomyopathies or digestive tract pathologies (Rassi et al.,
2010).
As a consequence of the varying degrees of environmental
stress faced, the life cycle of T. cruzi comprises a great variety of
extracellular and intracellular forms, from highly replicative
epimastigotes to low replicative intracelular amastigote
forms or metabolically quiescent metacyclic and bloodstream
trypomastigotes. It is thus conceivable, that kinetics, yields and
composition of EVs will be extremely affected by the varying
biological nature of the different developmental stages as well
as the micro-/macroenvironmental physiology present in the
tissues where they thrive. Given the variety of T. cruzi and host
EVs described so far [exosomes, MVs (= ectosomes)], herein the
term EVs will be used from now on for reasons of clarity unless
specified.
Could EVs Be Mediators of Local
Signaling in Chagas Disease?
Generally speaking, EV uptake and delivery is potentiated in
disease conditions that are, in turn, affected by the patient’s
particular status. To mediate an effect on the receptor cell,
the released EVs utilize the following routes for targeting
cells: endocrine (distant cells), paracrine (neighboring cells),
juxtacrine (adjacent cells) or autocrine (self-targeting) signaling.
Theoretically, three ways of EV transfer could occur between cells
during a parasitic disease: parasite–parasite, parasite–host cell,
or host cell–host cell (Figure 2A). These three scenarios will be
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FIGURE 2 | Types of EV transfer and interaction in acute and chronic phases of Chagas disease. (A) EVs could be released by Trypomastigote or Amastigote forms
during Acute and/or Chronic phase of the disease. This secretion could be mediated between parasites, parasites and its host cells or between infected and
uninfected cells mediating Autocrine, Yuxtacrine, or Paracrine type of signaling. EVs could be also released to the bloodstream or lymphatic fluids for distant
endocrine targeting. During Chronic phase endocrine signaling may mediate changes for tissue re-education, colonization, and further inflammation. (B) Scanning
electron microscopy of a MT invading a host cell. The right figure shows a magnified image of the MT point of contact with the host cell membrane. The gray arrows
indicate the EVs of different sizes that may derive from both parasite and host cell. This picture corresponds to an infection of Vero Cells with MTs (strain PAN4 DTU
Ia) for 2 h and belongs to the same series of scanning microscopic pictures published in Díaz Lozano et al. (2017).
clearly influenced by the phase of the disease (acute or chronic)
and the patient’s status (immunodepressed, co-infections, etc.)
with dynamically fluctuating levels of parasitemia and foci of
infection. In the particular case of Chagas disease, the levels
of circulating bloodstream trypomastigotes in pediatric patients
could vary from almost 1,000 parasites/ml to 1 parasite per ml or
less. The number can reach up to 1,400 parasites/ml in reactivated
Chagas in patients with T. cruzi/HIV co-infection (Duffy et al.,
2009; de Freitas et al., 2011). These figures are far below those
reached in patients suffering from African sleeping sickness
disease, in whom bloodstream trypomastigotes of Trypanosoma
brucei rhodesiense replicate extracellularly reaching waves of
parasitemia of more than 106 organisms per milliliter (Pépin
and Méda, 2001). This high yield of parasites in blood could
potentially lead to a parasite–parasite paracrine EV transfer.
Indeed, T. brucei EVs are able to transfer proteins [including
virulence factors such as the serum resistance associated (SRA)
protein] to recipient trypanosomes (Szempruch et al., 2016).
Due to the lower yields in blood of bloodstream trypomastigotes
of T. cruzi, it is reasonable to assume that the intracellular
stages should mainly be responsible for parasite–parasite but
also parasite–host cell EV transmission through paracrine and/or
juxtacrine signaling, since they develop in a compartmentalized
environment, increasing the likelihood of EV docking and
delivery within the host cell. The ability of the amastigote
stage to deliver EV protein cargoes with important effects to
the host cell have been demonstrated in macrophages infected
with the kinetoplastid parasite Leishmania major (Silverman and
Reiner, 2012). This parasite is able to release via EVs virulence
factors such as the metalloproteinase gp63. This release results
in the activation of multiple protein-tyrosine phosphatases of
the host cell implicated in the dephosphorylation of IFN-γ/Jak-
STAT1 pathway and thus inhibiting the activation of macrophage
microbicidal functions. Since, extracellular T. cruzi EVs also
carry proteins belonging to the gp63 multigene family (Bayer-
Santos et al., 2013), it is reasonable to think that the T. cruzi
intracellular stage could also release this protein which would
also have an important implications for the parasite intracellular
survival.
The most frequently studied scenario to date is the
paracrine/juxtacrine cross talk between parasite and host cell
EVs (Figure 2B). In this context, Ramirez et al. (2017) studied
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MVs (= ectosomes) subpopulation of EVs from the host cell
and parasite and demonstrated that the close contact between
membranes results in the fusion of a bidirectional MVs (parasite–
host and vice versa) on both the parasite and the host membranes.
Moreover, the same authors demonstrated that tissue-cultured
trypomastigote (TCT) MVs have the highest fusogenic potential
for host cell membranes and that TCT forms have the highest
rates of incorporation into the host cell, highlighting the
differences among the various forms of T. cruzi (Ramirez et al.,
2017). Cestari et al. (2012) showed that T. cruzi MTs and
TCTs [but not epimastigote (E) forms] stimulate up to 3- to
4-fold the secretion of plasma membrane derived MVs in THP-
1 monocyte cells after 60 min of exposure to the parasites
(Cestari et al., 2012). Moreover, these authors also demonstrated
that this host-MVs secretion is: (i) elevated independently of
the T. cruzi strain used for infection and (ii) the secretion
of host-EVs is induced in a Ca2+ dependent manner. This
latter finding is in accordance with other cell types such as
hematopoietic or neuroblastoma human cell lines (Savina et al.,
2003; Emmanouilidou et al., 2010) where the increase in intra-
cytosolic Ca2+ induce a strong ectosome-shedding response.
Indeed, it has been demonstrated in different eukaryotic cell types
that elevated intracellular levels of Ca2+ induces an asymmetric
phospholipid distribution in plasma membrane by activating
scramblase and flopase enzymes exposing phosphatidylserine
and phosphatidylethanolamine (PS) in the outer leaflet and
contributing to the activation of Ca2+-dependent proteases
followed by ecotosome release (Yáñez-Mó et al., 2015). In this
sense, the interaction of TCT forms with THP-1 monocytes
leads to the increase of the PS exposure in MVs released upon
this infection, being particularly increased compared to MT or
E forms (Cestari et al., 2012). Accordingly, the PS exposure
an subsequent release of MVs phenomena have already been
described in THP-1 monocytes in exposure to different stimuli
such agonists of ATP or lipopolysaccharides (LPSs) (MacKenzie
et al., 2001; Liu et al., 2006; Pap et al., 2009). The higher
exposure of anionic phospholipids such as PS on infected host
cell EVs increases the fusogenic properties of these vesicles, which
could be a pre-requisite for the exchange of information via
MVs. The mobilization of Ca2+ from intracellular deposits has
also been extensively studied during the process of T. cruzi-
host cell invasion having several consequences for the host
cell such as depolarization of host plasma membrane, F-actin
depolymerization or lysosomal recruitment to the point of
infection (Osuna et al., 1986; Tardieux et al., 1994; Caler et al.,
2000; Scharfstein et al., 2000). Although the precise signaling
cascades by which T. cruzi stimulates MVs and/or any other type
of EV secretion in the host are still unknown, this data clearly
show that the kinetics of host MV secretion is influenced by
the presence of the parasite and subsequent Ca2+ release from
intracellular deposits.
Additionally, Ramirez et al. (2017) also suggested that
parasite-derived factors are capable to be revesiculated into
host MVs. Although this fact still need to be experimentally
demonstrated, the capacity of packing parasite proteins by
host cells has been previously reported in EVs released
from Plasmodium falciparum infected erythrocytes, enriched in
P. falciparum membrane-associated parasite antigens (Mantel
et al., 2013). In this context, early research demonstrated that
paracrine/juxtacrine transfer of parasite proteins between T. cruzi
infected host cell-to-uninfected host cells could be found in
muscle, neuronal, epithelial, or fibroblast cells infected with
amastigotes (Santos and Hudson, 1980; Pinho et al., 2002).
Strikingly, this transfer of T. cruzi antigens could not be
detected in lymphocyte or erythrocyte cell lines, suggesting
that EV transfer is restricted to compatible cells and/or tissues
(Pinho et al., 2002). In anycase, the infection of host cells
with T. cruzi will induce the release of EVs that will have
an impact in the physiological status of surrounding cells.
This changes were studied by the work of Chowdhury et al.
(2017) where EVs released by infected human peripheral blood
mononuclear cells (PMBCs) with SylvioX10/4 strain of T. cruzi
were isolated and incubated with THP-1 human monocites. It is
worth noting that the authors used larger EVs (apoptotic bodies
and/or microvesicles) for the study since the EVs purification
protocol does not included ultracentrigugation steps, therefore
without the exosomal fraction of EVs. After the exposure to
apoptotic bodies and microvesicles, THP-1 cells were activated
showing a proinflammatory gene expression profile with an
increase in nitric oxide and reactive species of oxygen (ROS)
(Chowdhury et al., 2017), which is in accordance with the
presence of this activated immune phenotypes in chronic
inflammatory pathology of Chagas disease. Therefore, strong
evidence suggests that T. cruzi clearly influences the host-
cell juxtacrine/paracrine EV release and that this situation
should have a strong impact on the surrounding infected
tissue.
Could EVs Be Mediators of T. cruzi
Tissue Biotropisms and Distant Signaling
in Chagas Disease?
Due to the constitutive nature of EV secretions in cells, the
presence of EVs has been detected in numerous body-fluids
(nasal secretion, urine, blood, feces, breast milk, etc.) and
particularly in those where T. cruzi proliferates (Keller et al.,
2006). Under disease conditions, EV secretion has been shown
to be exacerbated in the bloodstream of patients suffering from
acute and chronic inflammation evoked by diseases such as sepsis,
stroke, preeclampsia, atherosclerosis, diabetes mellitus, metabolic
syndrome, or cancer (Yamamoto et al., 2016). This increase in
circulating EVs has also been demonstrated during infection with
Plasmodium spp., and their plasma levels associated with the
severity of the disease (Mantel and Marti, 2014). Accordingly,
in vivo infection with T. cruzi showed a rapid increase of EVs
levels in mouse plasma (Cestari et al., 2012), which suggests
a regulated secretion triggered and or increased by external
cues. This increase and changes in the kinetics of host EV
secretion give must be intuitively guided by factors such as the
initial parasite inoculum [i.e., 50 MTs are sufficient to detect an
immune response in immunocompetent mice (Mendes et al.,
2013)] or the stage of the disease (acute or chronic). In this
context, in vitro experiments have shown that EV secretion
is stimulated by different stress factors such as heat, hypoxia,
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and/or irradiation (Yu et al., 2006; Díaz Lozano et al., 2017;
Zheng et al., 2017). For instance, human non-small cell lung
cancer lines treated with γ-radiation resulted in an increase
of exosome release regulated by the activation of the tumor
suppressor p53 oncogene (Yu et al., 2006). This fact was also
observed during the course of T. cruzi infection in experimental
infections of CD1 mice with the Brazil strain of parasites,
showing that the p53 protein is upregulated in the liver 45 days
post-infection, which might result in an elevated secretion of
liver EVs into the bloodstream of patients with acute Chagas
disease (Bouzahzah et al., 2006). These findings contrast with
the transcriptome analysis of experimental in vitro infections
of human foreskin fibroblast with the Y strain of T. cruzi
not resulting in an increase of p53 mRNA (Li et al., 2016).
Therefore and due to the distinct nature of EV populations and
multifactorial responses that will trigger the release of EVs, future
research must carefully analyze the possible relation between
the p53 pathway and EVs secretion in the context of Chagas
disease.
Variations in Chagas disease presentation, progression, and
differential organ involvement are influenced by both host
and parasite factors (Dutra and Gollob, 2008). The phenotypic
analysis of large size circulating EVs (apoptotic bodies and
microvesicles) in chronic Chagasic patients and mice chronically
infected with T. cruzi showed that <2% of the vesicles come from
platelet or cardiomyocyte, being the majority of those vesicles
from monocyte/macrophage (CD14+), endothelial (CD62+)
and CD4+/CD8+ T lymphocytes (Chowdhury et al., 2017). To
date, there is little information on the implication of T. cruzi
EVs in endocrine signaling and its link to tissue tropisms has,
so far, neither been correlated. The probability of T. cruzi EV
docking and targeting distant cells would mainly depend on the
cell microenvironment of the infected tissue and its distance
to the appropriate transport media (i.e., blood and lymphatic
fluid). Different studies, have shown that the time for clearance
of purified and labeled EVs from different cell types artificially
introduced into the bloodstream range between a short half-
life of 2 min for EVs from CD169+ cells (leukocytes and
stromal cells) (Saunderson et al., 2014) to 20 min in human
embryonic kidney cells (Saunderson et al., 2014) and to 5.5 h
for platelet EVs (Rank et al., 2011). The values reached in
the case of lymphatic fluid reflect extraordinary speed, i.e.,
exosomes could be distributed into lymphatic nodes within 5 min
after injection into the tip of a mouse tail (Srinivasan et al.,
2016). Once cleared from the bloodstream or lymphatic fluid,
labeled EVs show a wide endocrine signaling distribution in
a plethora of tissues where they will be cleared with different
kinetics. In this sense, a great deal of research has demonstrated
the relation of exosomes with the “soil and seed” hypothesis
in cancer disease (Ali and Arbab, 2014). These reports have
shown that during a cancerous process, endocrine signaling and
metastasis formation is induced by the secretion of exosomes
derived from tumors (EDTs). For instance, EDTs secreted by
pancreatic cancer cells target Kupffer cells that prepare the
premetastatic niche in the liver by secretion of TGF-β and
subsequent mobilization of bone marrow derived cells (BMDCs)
together with an increase in the production of fibronectin that
generates the necessary conditions for liver metastasis (Costa-
Silva et al., 2015). This process of generation of premetastatic
niches by EDTs has also been recently described in the case of
melanoma or breast cancer (Hoshino et al., 2015; García-Silva
and Peinado, 2016). Furthermore, the injection with EDTs of
breast cancer cell sub-lines with a high colonization capacity
is capable of reeducating and activating cell lines marked
with luciferase with low migratory capacity (Hoshino et al.,
2015).
In this sense, it is conceivable that the “soil and seed” role of
EDTs could have its analogy in diseases caused by pathogens such
as T. cruzi (Figure 2A). First hints of this possible T. cruzi EVs
endocrine signaling has been provided by Trocoli Torrecilhas
et al. (2009). The injection of 5 µg EVs from trypomastigotes
of T. cruzi (Y strain) into Balb/c mice 7 days prior to infection
with the parasite led to substantially increased virulence of
the infection (100% mortality, 22 days post-infection), with
an increase in amastigote nests in heart sections. Moreover,
recent work from Chowdhury et al. (2017) have shown that
circulating host EVs (apoptotic bodies and/or microvesicles)
isolated from blood of Chronic chagasic patients are capable
to trigger an increase in IL-1β, IL-7 and IFN- γ cytoquines,
ROS and NO production in macrophages, fact that was specially
exacerbated in seropositive individuals who exhibited clinical
disease when compared to seropositive chronic individuals with
no clinical symptoms (Chowdhury et al., 2017). These EVs
have been shown to be of monocyte/macrophage, endothelial
and CD4+/CD8+ T lymphocytes, therefore, circulating host
EVs will contribute to the inflammatory response observed in
individuals with chronic Chagas disease via endocrine signaling.
This possible endocrine effect of T. cruzi and host EVs during
the disease could be related to: (i) the direct effect of EVs on
target tissue via endocrine signaling, (ii) paracrine/endocrine
immune cell activation (see below) and subsequent signaling.
Bioluminescence imaging of chronic infections has shown that
tissue damage is linked to a tenacious persistence of T. cruzi
in tissues. Lewis et al. (2014) showed that (at least for the
CL-Brener strain) the colon and stomach are permanent parasite
reservoirs for the disease, where parasites are found in discrete
foci of infection (Lewis et al., 2014). Surprisingly, infection
in hearts was rather sporadic and non-persistent, showing
a bioluminescence ranging from 10 to 80% of the animals
depending on the strain (Lewis et al., 2014). More strikingly,
the same authors found that while the gut was continuously
infected, the foci were highly spatially dynamic, with changes
in luminescence of less than 24 h. The most parsimonious
interpretation is that infected phagocytes could be circulating to
and from peripheral sites. However, another possible explanation
could be related to a vehiculization of the firefly luciferase
protein ectopically expressed on the bioluminescent parasites
into EVs and further release to surrounding or distant locations
from the foci of infection in a paracrine/endocrine manner.
Indeed, the integration into EVs of ectopically expressed
cytosolic fluorescence markers such as GFP was observed
by Bayer Santos in EVs (Bayer-Santos et al., 2013), making
this scenario highly probable. In this respect, further studies
to clarify the role of EVs in tissue tropisms and distant
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FIGURE 3 | Trypanosoma cruzi EV protein composition. (A) Schematic representation of protein components described in T. cruzi EVs. Note that for the purpose of
the figure, the different components were not represented in the scale or density of molecules. Only representative proteins from each protein group (surface,
peptidases, metabolic enzymes, conserved cytosqueletal, antioxidant, RNA and DNA related proteins) are represented. (B) Venn diagram of T. cruzi (n = 237)
(Bayer-Santos et al., 2013), Leishmania major (n = 261) (Silverman et al., 2010), and Trypanosoma brucei (n = 191) (Szempruch et al., 2016) EVs proteomic datasets
(hypothetical proteins has been excluded from the analysis). (C) List of T. cruzi, L. major, and T. brucei EV proteins also found among the top 100 most frequently
found vesicular proteins in mammalian EVs (Choi et al., 2013).
signaling, and the implications for disease pathogenesis will be
needed.
Specific and Non-specific T. cruzi EV
Protein Cargoes
Proteomics has revealed the complex composition of EVs in any
cell type (Choi et al., 2015). Whether or not vesicular cargo
sorting and vehiculization of selected intracellular proteins in
EVs is a fine-tuned regulated process or a simple constitutive
release stimulated by types of stress, these components are
not passive actors once released from the cell as well as
necessary for cell-to-cell communication. To date, the best
proteomic description of T. cruzi EVs has been provided
by Bayer-Santos et al. (2013). The authors purified and
analyzed the proteomic composition of three EV populations:
ectosome, exosome (of 143 and 87 nm mean diameter,
respectively) and vesicle-free fractions of T. cruzi epimastigote
and MT forms. Overall, the comparison of E and MT EVs
showed a consistent core of 70.4% (243/34) proteins shared
in both stages. Only 35.8% of the EV protein composition
was stage-specific (29.5% E-specific and 6.44% MT-specific
respectively) confirming that independently of the stage, a
large proportion of the T. cruzi secretome is constitutively
released via EVs (Bayer-Santos et al., 2013) (Figure 3A). In
this context, it is worth noting that EV proteins present
in E and MT stages should not be discarded as potential
virulence factors but rather be considered as released proteins
that would play a different role and have different targets in
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the E (extracellular, insect vector) and MT (extra/intracellular,
mammalian host) niches inhabited by parasites. For instance,
it has been demonstrated that surface GPI-anchored members
of the trans-sialidase family of genes gp82 and gp35/50,
which are required for the parasite’s ability for invading the
mammalian host cells, are also released in epimastigote EVs,
supporting the idea of the dual role in the different stages
of the life cycle (De Pablos and Osuna, 2012). Changes
in the localization of parasite proteins delivered in EVs
might modify their biological activity, which would make the
EV protein content either multifunctional or able to switch
between targeting molecules (host and parasite and vice versa).
Moreover, different post-translational modifications (PTMs) in
the E/M shared EVs core of proteins might dictate changes in
vesicle localization, protein targets, and/or biological functions.
Indeed, 96 out the top 100 proteins mostly identified in
mammalian exosomes were reported to carry PTMs such as
phosphorylation, acetylation, ubiquitination, or glycosylation
which would act in different combinatorial ways to alter
the protein properties within EVs (Rosa-Fernandes et al.,
2017).
Proteomic profiles of EVs are highly dependent on how EVs
are isolated (Yáñez-Mó et al., 2015). Different methodologies
could result in difficulties for extrapolation and comparisons
among distinct cell types. To date, all proteomic analyses
performed in kinetoplastids used differential ultracentrifugation
as the method of choice, thus variations among these analyses
could be due to the varying biological properties of the different
parasite kinetoplastid forms (translational activity, metabolic
status, cell density, etc.) or culture conditions including pH,
temperature or CO2.
The comparison of T. cruzi MT EVs (either ectosomes
or exosomes) with L. donovani stationary-phase promastigote
exosomes (30–70 nm diameter; n = 261) (Silverman et al., 2010)
and T. brucei bloodstream nanotubule derived-EVs (median
average of 80 nm diameter with a minimum population
of 165 nm size diameter; n = 155) (Szempruch et al.,
2016) led to a total of 35 shared proteins (Figure 3B
and Supplementary Data Sheet S1). Within this common
kinetoplastid EV core of proteins, 37.1% (13/35) were also
found in the top 100 vesicular proteins most frequently
found in mammalian EVs (Choi et al., 2013) (Figure 3C).
In the particular case of T. cruzi, 28 proteins where also
found in this mammalian dataset, which shows that T. cruzi
shares some commonalities in secreted proteins via EVs
with higher eukaryotes such as Rattus norvegicus, Homo
sapiens, Bos taurus (Choi et al., 2013). Interestingly, T. cruzi
shares more proteins with L. major (60) than T. brucei (7),
which may be explained by higher commonalities between
L. major stationary phase promastigote forms (enriched in
metacyclic promastigotes) and MT forms of T. cruzi (De
Pablos et al., 2016b), with both stages being non-replicative
quiescent stages and able to invade host cells. However, this
later assumption may be difficult to interprete as, in turn,
L. major shares in turn 63 proteins with an extracellular
replicative stage such as the bloodstream forms of T. brucei
(Figure 3B).
The genomes of these three parasites have a total of
6158 syntenic genes, which is approximately half of the
T. cruzi gene content (Kissinger, 2006). Conversely to the
large proportion of the core genome shared by kinetoplastid
parasites, proteomic analyses of EVs performed so far have
revealed more differences than commonalities among these
parasites, with 56.7% (135/238) of T. cruzi EV proteins
exclusively found in this parasite. Within this subset of
T. cruzi-EV cargoes, T. cruzi contains numerous members
of multigenic families of GPI-anchored surface proteins such
as trans-sialidases (TS), gp63, mucins, or mucin-associated
surface proteins (MASPs) that are usually exposed in the outer
leaflet of the plasma membrane (De Pablos and Osuna, 2012).
Western blot, immunoelectron microscopy, and proteomic
analysis have demonstrated the presence of these surface
molecules in E, MT as well as TCT EVs (Bayer-Santos
et al., 2013; De Pablos et al., 2016a; Lantos et al., 2016;
Díaz Lozano et al., 2017). Interestingly, TSs are preferentially
encapsulated in parasite-derived microvesicles (= ectosomes),
while its soluble form could be cleaved of its GPI-anchor via
phosphatidylinsositol-phopholipase-C (PI-PLC) (Lantos et al.,
2016). This group of TSs proteins has an essential enzymatic
role for T. cruzi, catalyzing the enzymatic transfer of syalic
acid from host glycoconjugates to parasite mucin residues. This
constant removal of syalic acid from host cells has important
pathophysiological implications during the acute phase of the
disease such as thrombocytopenia or apoptosis of immune
cells (Tribulatti et al., 2005). Since T. cruzi non-cleaved TS
shedding is preferentially routed via EVs, it is conceivable that
functional molecules delivered in EVs may be more active than
their soluble form (De Pablos and Osuna, 2012; Lantos et al.,
2016).
Additionally, T. cruzi EVs also carry a wide range of
potential virulence factors such as peptidases (calpain cysteine
peptidase, thimet oligopeptidase, thermostable carboxypeptidase
1, or aminopeptidase P), in charge of the proteolysis of different
peptide substrates (Alvarez et al., 2012) (Figure 3A). In this
respect, proteolytically active peptidases in EVs may target
proteins contained in the EVs or inside the host cell (Yáñez-Mó
et al., 2015).
Finally, proteomic studies have also shown that almost all
ribosomal subunit proteins were those present in T. cruzi
tissue cultured bloodstream trypomastigotes (TCT) (unpublished
results), L. donovani stationary phase promastigotes (Silverman
et al., 2010) or T. brucei bloodstream EVs (Szempruch
et al., 2016) (Figure 3A). Since the volume of an exosome
is comparable to the size of the ribosomal complex (4.2–
380 YL) (Vlassov et al., 2012), it may be difficult for intact
ribosomal complexes to be vehiculizated into exosomes, but
rather included in bigger vesicular compartments such as
ectosomes or apoptotic bodies, which could function for
the transfer of these cell components. This fact prompts
fundamental questions that should be studied in depth such
as: what is the functionality of parasite ribosomal proteins
contained in EVs? Or what is the potential for translation
of parasite mRNAs contained in EVs and the relevance of
these products inside the host cell? In this sense, proteomic
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studies have prepared the ground for further dissection and
study of the functionality and way of action of the EV protein
content.
New Passengers: EV-Derived Immune
Complexes (EV-ICs) and Immune
Response Against T. cruzi EVs
Immune cells are one of the main targets of EVs, especially
in the context of infectious diseases. Released EVs from
virus-infected cells, bacteria, fungi, or parasites have been
demonstrated to have a pivotal role in the modulation of
the immune system. Therefore, EVs secreted during acute
and/or chronic T. cruzi infection, should also play a role
in the dissemination and survival of this parasite in the
mammalian host. Indeed, several types of EVs of different
organisms have already been described as promoters of the
innate and acquired immune response and defined as types
of PAMPs (pathogen-associated molecular patterns) (Schorey
et al., 2015). Broadly, PAMPs could be formed by a wide
range of molecules (lipids, proteins, carbohydrates, or nucleic
acids) and are recognized by pattern recognition receptors
(PPRs) (such as TLRs) present in leukocytes and various non-
immune cells, which will in turn initiate a signaling cascade
that leads to the activation of an immune response against the
pathogen (Schorey et al., 2015). Several PAMPs have already
been described for T. cruzi, for instance, parasite CpG-DNA
released from lysed intracellular parasites stimulates TLR7
and 9 activation and production of Th1 proinflammatory
cytokines or parasite α-Gal-containing glycoconjugates (such
as mucins or gp85/TS) recognized by TLR2/6 leading to
TNF-α production in macrophages and inhibition of IL-12 in
dendritic cells (Rodrigues et al., 2012; Gravina et al., 2013).
Accordingly, studies on T. cruzi EVs have shown that these
vesicles could act as an agonist of TLR2 signaling, which
leads to the secretion of proinflammatory cytokines (TNF-α
and IL-6) and nitric oxide (Nogueira et al., 2015). This fact
could be partially explained by the presence of GPI-anchored
molecules (mucins, MASPs, or TSs) on the EV surface (see
above). However, it has previously been demonstrated that
T. cruzi-PAMPs are poorly detected by the innate immune
system right at the onset of the disease, delaying the activation
FIGURE 4 | The new passengers. EVs could either target surrounding cells
(EVs) or be released to the cell body fluids where they will be targeted by
antibodies forming EV-ICs, which will influence the mechanisms of uptake into
the targeted cells, specially by immune cells expressing Fc-gamma receptors
on their surfaces.
of the immune response most probably after the initial round
of exit (approximately after the 4th to 5th day post-infection)
from infected host cells, thus delaying the development of a
protective immune response. In relation to the parasite and its
secreted EV products, this delay may be explained by several
factors: (i) the parasite invades tissues rather than immune cells
immediately after the initial infection, with poor migration to
surrounding tissues or draining lymph nodes (Cardoso et al.,
2016), (ii) the initial inoculum and/or slow growth kinetics
of the amastigote stage (slower than virus or bacteria) might,
in turn, influence the minimum threshold for dendritic cell
and/or phagocyte PPRs activation by EVs in vivo, (iii) the
polyclonal B cell activation and hypergammaglobulinemia shown
during the early phase of the disease will delay a parasite
specific antibody response (Minoprio et al., 1988). In this
sense, it is only in the third week of acute infection when
parasite-specific IgGs (dominated by the IgG2a isotype) are
detected in mice infected with T. cruzi (Bermejo et al., 2011).
Therefore, IgG antibodies should poorly target EV antigens
during the first 3 weeks of the disease, which could be recognized
from the third week onward, when parasite-specific antibodies
are raised in the serum of an infected host. Thereafter, the
parasite disappears from the blood and establishes a chronic
infection. With these observations, it is reasonable to think
that these differences in antibody response might create two
different populations of EVs during the disease, antibody-free
EVs and antibody-coated EVs, which are synonymous for EV-
derived circulating immune complexes (EV-ICs), whose presence
have been demonstrated by some of us (Díaz Lozano et al.,
2017) (Figure 4). During adaptive immune responses, immune
complexes form when antibodies interact with their specific
epitopes on soluble antigens. Immunoglobulin G (IgG) immune
complexes target Fc-gamma receptors on immune cells such as
dendritic cells to shuttle exogenous antigens efficiently into the
cross-presentation pathway (Platzer et al., 2014). This receptor-
mediated cross-presentation pathway is a well-described route
for the induction of a strong CD8+ T cell response (Platzer
et al., 2014). Using MASP conserved regions as an antigen
source, it has been demonstrated that circulating parasite
EVs are targeted by the immune system to form EV-ICs in
chronic chagasic patients, especially in those associated with
digestive pathologies (Díaz Lozano et al., 2017). In accordance,
proteomic profiling of circulating immune complexes identified
up to 39 antigens that show an associated humoral immune
response. Interestingly, the antibody EV-targeting in the serum
of chronic phase patients has also been found in host cell-
infected derived EVs (Ramirez et al., 2017). Therefore, several
combinations of parasite- and/or host cell derived-EVs or
EV-IC populations activating juxtacrine, paracrine, or endocrine
signaling could potentially prime a differentially associated
immune response. Furthermore, Cestari et al. (2012) have shown
that the parasite is able to evade the action of the immune
complement system mediated by depositing host-cell derived
EVs on its surface, which inhibits the action of complement
C3 convertase. Also, T. cruzi complement regulatory protein
(CRP) and MASP conserved N- and C- terminal regions have
been found in as part of trypomastigote secreted EV cargoes
Frontiers in Microbiology | www.frontiersin.org 8 June 2018 | Volume 9 | Article 1190
fmicb-09-01190 May 30, 2018 Time: 18:26 # 9
de Pablos Torró et al. Extracellular Vesicles in Chagas Disease
(De Pablos et al., 2016a; Díaz Lozano et al., 2017) and allow the
parasite to evade the complement immune system (Norris et al.,
1991). Altogether, parasite EVs could (i) contribute to immune
evasion (Norris et al., 1991; Cestari et al., 2012) (ii) activate
the release of proinflammatory cytoquines, modulating the host
immune response and (iii) free, together with circulating EV-
ICs, would play a differential role activating a variety of immune
cells.
CONCLUSION
The active communication between T. cruzi and its host
is a bidirectional process in which millions of EVs from
both organisms participate. The final outcome would involve
specific parasite tropisms and changes in immune status
of the host during the chronic phase, where EVs are
constantly disseminated. As reflected in this review, to date
researchers have characterized only the tip of this iceberg,
which has far-reaching implications in the immune response,
infectivity and thus the survival of the parasite inside its
host. Thus, more studies should be performed to define
the biology of this complex subcellular compartment and
its physiological implications during the course of Chagas
disease.
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